Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancer.
Ferrucci
Pier Francesco
PF
Divisions of Hemato-oncology and Biostatistics and Epidemiology, European Institute of Oncology, Milan, Italy.
Rabascio
Cristina
C
Mazzetta
Chiara
C
Cocorocchio
Emilia
E
Agazzi
Alberto
A
Vanazzi
Anna
A
Cinieri
Saverio
S
Peccatori
Fedro A
FA
Paolucci
Mara
M
Bertolini
Francesco
F
Martinelli
Giovanni
G
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000097:blood* / Q000378:metabolism; D045744:Cell Line, Tumor; D002478:Cells, Cultured; D018572:Disease-Free Survival; D004305:Dose-Response Relationship, Drug; D004847:Epithelial Cells / Q000378:metabolism; D006801:Humans; D007633:Keratins / Q000097:blood; D019394:Ki-67 Antigen / Q000097:blood; D007937:Leukapheresis; D008207:Lymphatic Metastasis; D060785:Mammaglobin A; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009363:Neoplasm Proteins / Q000097:blood*; D011379:Prognosis; D016016:Proportional Hazards Models; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000097:blood; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012680:Sensitivity and Specificity; D013997:Time Factors; D016896:Treatment Outcome; D014598:Uteroglobin / Q000097:blood*
D007633:Keratins; D019394:Ki-67 Antigen; D060785:Mammaglobin A; D009363:Neoplasm Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases; D014598:Uteroglobin; C556448:SCGB2A2 protein, human